Skip to main content
SpringerLink
Log in

ACMT Position Statement: Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder

  • Position Statement
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

No datasets were generated or analysed for the authorship of this manuscript.

References

  1. Centers for Disease Control and Prevention. U.S. overdose deaths in 2021 increased half as much as in 2020-but are still up 15%. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm. Accessed 12/23/22.

  2. Suen LW, Makam AN, Snyder HR, Repplinger D, Kushel MB, Martin M, Nguyen OK. National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014–2018. J Gen Intern Med. 2022;37(10):2420–8. https://doi.org/10.1007/s11606-021-07069-w.

    Article  PubMed  Google Scholar 

  3. Cernasev A, Hohmeier KC, Frederick K, Jasmin H, Gatwood J. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. Explor Res Clin Soc Pharm. 2021;2:100029. https://doi.org/10.1016/j.rcsop.2021.100029.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Saloner B, Li W, Bandara SN, McGinty EE, Barry CL. Trends in the use of treatment for substance use disorders, 2010–19. Health Aff (Millwood). 2022;41(5):696–702. https://doi.org/10.1377/hlthaff.2021.01767.

    Article  PubMed  Google Scholar 

  5. Greater New York Hospital Association. The Opioid Workforce Act of 2021. https://www.gnyha.org/position/opioid-workforce-act/. Accessed 1 June 2023. 

  6. Hendrickson RG, Bania TC, Baum CR, Greenberg MI, Joldersma KB, Keehbauch JN. The 2021 core content of medical toxicology. J Med Toxicol. 2021;17(4):425–36. https://doi.org/10.1007/s13181-021-00844-5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Laes JR. The integration of medical toxicology and addiction medicine: a new era in patient care. J Med Toxicol. 2016;12(1):79–81. https://doi.org/10.1007/s13181-015-0523-7.

    Article  CAS  PubMed  Google Scholar 

  8. American College of Medical Toxicology. Interpretation of urine analysis for cocaine metabolites. J Med Toxicol. 2015;11(1):153–4. https://doi.org/10.1007/s13181-013-0360-5.

    Article  PubMed Central  Google Scholar 

  9. Connors N, Kosnett MJ, Kulig K, Nelson LS, Stolbach AI. ACMT position statement: interpretation of urine for tetrahydrocannabinol metabolites. J Med Toxicol. 2020;16(2):240–2. https://doi.org/10.1007/s13181-019-00753-8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stolbach A, Connors N, Nelson L, Kulig K. ACMT position statement: interpretation of urine opiate and opioid tests. J Med Toxicol. 2022;18(2):176–9. https://doi.org/10.1007/s13181-021-00864-1.

    Article  PubMed  Google Scholar 

  11. Wei J, Defries T, Lozada M, Young N, Huen W, Tulsky J. An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits. J Gen Intern Med. 2015;30(3):365–70. https://doi.org/10.1007/s11606-014-2968-9.

    Article  PubMed  Google Scholar 

  12. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care. 2000;38(1):7–18. https://doi.org/10.1097/00005650-200001000-00003.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the participation of the collaborators on this position statement. Collaborators: Jeffrey Brent, Joseph E. Carpenter, JB Hack, Hong K. Kim, Michael Moss, and Adam K. Rowden.

Funding

None.

Author information

Authors and Affiliations

  1. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Andrew I. Stolbach

  2. MedStar Washington Hospital Center, Washington, DC, USA

    Maryann Mazer-Amirshahi

  3. Jackson Memorial Hospital, Miami, FL, USA

    John Cienki

  4. Department of Emergency Medicine, Wright State University Boonshoft School of Medicine, Dayton, OH, USA

    Leslie R. Dye

  5. Rutgers New Jersey Medical School, Newark, NJ, USA

    Lewis S. Nelson

  6. Departments of Emergency Medicine & Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA

    Ryan Marino

  7. National Institute On Drug Abuse, Bethesda, MD, USA

    Stephanie T. Weiss

  8. National Institutes of Health, Bethesda, MD, USA

    Stephanie T. Weiss

  9. University of New Mexico School of Medicine, NM, Albuquerque, USA

    Brandon J. Warrick

  10. American College of Medical Toxicology, Phoenix, AZ, USA

    Paul M. Wax

Authors
  1. Andrew I. Stolbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryann Mazer-Amirshahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Cienki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leslie R. Dye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lewis S. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ryan Marino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephanie T. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Brandon J. Warrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paul M. Wax
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew I. Stolbach.

Ethics declarations

Conflicts of Interest

Dr. Weiss is supported by the Intramural Research Program of the NIH, NIDA.

Disclaimer

While individual practices may differ, this is the position of the American College of Medical Toxicology at the time written, after a review of the issue and pertinent literature.

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stolbach, A.I., Mazer-Amirshahi, M., Cienki, J. et al. ACMT Position Statement: Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder. J. Med. Toxicol. 19, 411–413 (2023). https://doi.org/10.1007/s13181-023-00945-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-023-00945-3

Keywords

Search

Navigation